_id
691728f83c536f8df2316cdb
Ticker
VIR
Name
Vir Biotechnology Inc
Exchange
NASDAQ
Address
1800 Owens Street, San Francisco, CA, United States, 94158
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.vir.bio
Description
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.
Last Close
6.63
Volume
3513594
Current Price
6.69
Change
0.9049773755656184
Last Updated
2025-12-05T13:26:02.340Z
Image
https://logo.clearbit.com/www.vir.bio
Ipo Date
2019-10-11T00:00:00.000Z
Market Cap
943267712
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.988
Sentiment Sources
2
Rating
4
Target Price
17.2222
Strong Buy
2
Buy
5
Hold
2
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
240000
Cost Of Revenue
151452000
Gross Profit
-151212000
Operating Expenses
22231000
Operating Income
-173443000
Interest Expense
-
Pretax Income
-162973000
Net Income
-163141000
Eps
-1.1742661545523303
Dividends Per Share
-
Shares Outstanding
139125032
Income Tax Expense
168000
EBITDA
-159975000
Operating Margin
-72267.91666666667
Total Other Income Expense Net
10470000
Cash
170084000
Short Term Investments
336429000
Receivables
4000000
Inventories
-
Total Current Assets
545684000
Property Plant Equipment
121758000
Total Assets
1019453000
Payables
6847000
Short Term Debt
8960000
Long Term Debt
-
Total Liabilities
223355000
Equity
796098000
Depreciation
2998000
Change In Working Capital
-20601000
Cash From Operations
-167570000
Capital Expenditures
317000
Cash From Investing
40446000
Cash From Financing
102000
Net Change In Cash
-127023000
PE
-
PB
1.1674980434192774
ROE
-20.492577546985423
ROA
-16.002797578701518
FCF
-167887000
Fcf Percent
-699.5291666666667
Piotroski FScore
0
Health Score
34
Deep Value Investing Score
5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
6.5
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
240000
Quarters > 0 > income Statement > cost Of Revenue
151452000
Quarters > 0 > income Statement > gross Profit
-151212000
Quarters > 0 > income Statement > operating Expenses
22231000
Quarters > 0 > income Statement > operating Income
-173443000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-162973000
Quarters > 0 > income Statement > net Income
-163141000
Quarters > 0 > income Statement > eps
-1.1742661545523303
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
138930173
Quarters > 0 > income Statement > income Tax Expense
168000
Quarters > 0 > income Statement > EBITDA
-159975000
Quarters > 0 > income Statement > operating Margin
-72267.91666666667
Quarters > 0 > income Statement > total Other Income Expense Net
10470000
Quarters > 0 > balance Sheet > cash
170084000
Quarters > 0 > balance Sheet > short Term Investments
336429000
Quarters > 0 > balance Sheet > receivables
4000000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
545684000
Quarters > 0 > balance Sheet > property Plant Equipment
121758000
Quarters > 0 > balance Sheet > total Assets
1019453000
Quarters > 0 > balance Sheet > payables
6847000
Quarters > 0 > balance Sheet > short Term Debt
8960000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
223355000
Quarters > 0 > balance Sheet > equity
796098000
Quarters > 0 > cash Flow > net Income
-163141000
Quarters > 0 > cash Flow > depreciation
2998000
Quarters > 0 > cash Flow > change In Working Capital
-20601000
Quarters > 0 > cash Flow > cash From Operations
-167570000
Quarters > 0 > cash Flow > capital Expenditures
317000
Quarters > 0 > cash Flow > cash From Investing
40446000
Quarters > 0 > cash Flow > cash From Financing
102000
Quarters > 0 > cash Flow > net Change In Cash
-127023000
Quarters > 0 > ratios > PE
-1.1742661545523303
Quarters > 0 > ratios > PB
1.1674980434192774
Quarters > 0 > ratios > ROE
-20.492577546985423
Quarters > 0 > ratios > ROA
-16.002797578701518
Quarters > 0 > ratios > FCF
-167887000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-699.5291666666667
Quarters > 0 > health Score
34
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
1214000
Quarters > 1 > income Statement > cost Of Revenue
97520000
Quarters > 1 > income Statement > gross Profit
-96306000
Quarters > 1 > income Statement > operating Expenses
22111000
Quarters > 1 > income Statement > operating Income
-118417000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-110788000
Quarters > 1 > income Statement > net Income
-110958000
Quarters > 1 > income Statement > eps
-0.8014474853192919
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
138447000
Quarters > 1 > income Statement > income Tax Expense
170000
Quarters > 1 > income Statement > EBITDA
-115672000
Quarters > 1 > income Statement > operating Margin
-9754.283360790774
Quarters > 1 > income Statement > total Other Income Expense Net
7629000
Quarters > 1 > balance Sheet > cash
211104000
Quarters > 1 > balance Sheet > short Term Investments
394915000
Quarters > 1 > balance Sheet > receivables
5200000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
735706000
Quarters > 1 > balance Sheet > property Plant Equipment
125648000
Quarters > 1 > balance Sheet > total Assets
1192532000
Quarters > 1 > balance Sheet > payables
12234000
Quarters > 1 > balance Sheet > short Term Debt
8825000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
245060000
Quarters > 1 > balance Sheet > equity
947472000
Quarters > 1 > cash Flow > net Income
-110958000
Quarters > 1 > cash Flow > depreciation
9527000
Quarters > 1 > cash Flow > change In Working Capital
-25061000
Quarters > 1 > cash Flow > cash From Operations
-120219000
Quarters > 1 > cash Flow > capital Expenditures
2538000
Quarters > 1 > cash Flow > cash From Investing
56456000
Quarters > 1 > cash Flow > cash From Financing
2046000
Quarters > 1 > cash Flow > net Change In Cash
-61717000
Quarters > 1 > ratios > PE
-0.8014474853192919
Quarters > 1 > ratios > PB
0.9775596851410913
Quarters > 1 > ratios > ROE
-11.710952935812351
Quarters > 1 > ratios > ROA
-9.304404410112266
Quarters > 1 > ratios > FCF
-122757000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-101.11779242174629
Quarters > 1 > health Score
33
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
3032000
Quarters > 2 > income Statement > cost Of Revenue
117615000
Quarters > 2 > income Statement > gross Profit
-114583000
Quarters > 2 > income Statement > operating Expenses
24964000
Quarters > 2 > income Statement > operating Income
-139547000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-120949000
Quarters > 2 > income Statement > net Income
-120965000
Quarters > 2 > income Statement > eps
-0.8799438418843522
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
137469000
Quarters > 2 > income Statement > income Tax Expense
16000
Quarters > 2 > income Statement > EBITDA
-135660000
Quarters > 2 > income Statement > operating Margin
-4602.473614775725
Quarters > 2 > income Statement > total Other Income Expense Net
18598000
Quarters > 2 > balance Sheet > cash
273571000
Quarters > 2 > balance Sheet > short Term Investments
528091000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
932207000
Quarters > 2 > balance Sheet > property Plant Equipment
120240000
Quarters > 2 > balance Sheet > total Assets
1307727000
Quarters > 2 > balance Sheet > payables
3725000
Quarters > 2 > balance Sheet > short Term Debt
7925000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
263908000
Quarters > 2 > balance Sheet > equity
1043819000
Quarters > 2 > cash Flow > net Income
-120965000
Quarters > 2 > cash Flow > depreciation
2867000
Quarters > 2 > cash Flow > change In Working Capital
26059000
Quarters > 2 > cash Flow > cash From Operations
-78116000
Quarters > 2 > cash Flow > capital Expenditures
1629000
Quarters > 2 > cash Flow > cash From Investing
126818000
Quarters > 2 > cash Flow > cash From Financing
598000
Quarters > 2 > cash Flow > net Change In Cash
49300000
Quarters > 2 > ratios > PE
-0.8799438418843522
Quarters > 2 > ratios > PB
0.881060423310938
Quarters > 2 > ratios > ROE
-11.588694974895072
Quarters > 2 > ratios > ROA
-9.250019308311291
Quarters > 2 > ratios > FCF
-79745000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-26.301121372031663
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
12374000
Quarters > 3 > income Statement > cost Of Revenue
88789000
Quarters > 3 > income Statement > gross Profit
-76415000
Quarters > 3 > income Statement > operating Expenses
40735000
Quarters > 3 > income Statement > operating Income
-117150000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-104675000
Quarters > 3 > income Statement > net Income
-104589000
Quarters > 3 > income Statement > eps
-0.76448917834353
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
136809000
Quarters > 3 > income Statement > income Tax Expense
-86000
Quarters > 3 > income Statement > EBITDA
-100230000
Quarters > 3 > income Statement > operating Margin
-946.7431711653467
Quarters > 3 > income Statement > total Other Income Expense Net
12475000
Quarters > 3 > balance Sheet > cash
222947000
Quarters > 3 > balance Sheet > short Term Investments
682401000
Quarters > 3 > balance Sheet > receivables
5100000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1042458000
Quarters > 3 > balance Sheet > property Plant Equipment
122863000
Quarters > 3 > balance Sheet > total Assets
1398813000
Quarters > 3 > balance Sheet > payables
5081000
Quarters > 3 > balance Sheet > short Term Debt
7752000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
248428000
Quarters > 3 > balance Sheet > equity
1150385000
Quarters > 3 > cash Flow > net Income
-104589000
Quarters > 3 > cash Flow > depreciation
2886000
Quarters > 3 > cash Flow > change In Working Capital
-17001000
Quarters > 3 > cash Flow > cash From Operations
-87635000
Quarters > 3 > cash Flow > capital Expenditures
2407000
Quarters > 3 > cash Flow > cash From Investing
140737000
Quarters > 3 > cash Flow > cash From Financing
1263000
Quarters > 3 > cash Flow > net Change In Cash
54365000
Quarters > 3 > ratios > PE
-0.76448917834353
Quarters > 3 > ratios > PB
0.7956051321948739
Quarters > 3 > ratios > ROE
-9.091651925225033
Quarters > 3 > ratios > ROA
-7.476982269967465
Quarters > 3 > ratios > FCF
-90042000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-7.276709229028608
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
74205000
Annuals > 0 > income Statement > cost Of Revenue
478645000
Annuals > 0 > income Statement > gross Profit
-404440000
Annuals > 0 > income Statement > operating Expenses
182725000
Annuals > 0 > income Statement > operating Income
-587165000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-523105000
Annuals > 0 > income Statement > net Income
-521960000
Annuals > 0 > income Statement > eps
-3.8309834344976403
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
136247000
Annuals > 0 > income Statement > income Tax Expense
-1145000
Annuals > 0 > income Statement > EBITDA
-508912000
Annuals > 0 > income Statement > operating Margin
-791.2741728994004
Annuals > 0 > income Statement > total Other Income Expense Net
64060000
Annuals > 0 > balance Sheet > cash
222947000
Annuals > 0 > balance Sheet > short Term Investments
682401000
Annuals > 0 > balance Sheet > receivables
5100000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
1042458000
Annuals > 0 > balance Sheet > property Plant Equipment
122863000
Annuals > 0 > balance Sheet > total Assets
1398813000
Annuals > 0 > balance Sheet > payables
5081000
Annuals > 0 > balance Sheet > short Term Debt
7752000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
248428000
Annuals > 0 > balance Sheet > equity
1150385000
Annuals > 0 > cash Flow > net Income
-521960000
Annuals > 0 > cash Flow > depreciation
14559000
Annuals > 0 > cash Flow > change In Working Capital
-84007000
Annuals > 0 > cash Flow > cash From Operations
-446352000
Annuals > 0 > cash Flow > capital Expenditures
7301000
Annuals > 0 > cash Flow > cash From Investing
499367000
Annuals > 0 > cash Flow > cash From Financing
4388000
Annuals > 0 > cash Flow > net Change In Cash
57403000
Annuals > 0 > ratios > PE
-3.8309834344976403
Annuals > 0 > ratios > PB
0.8029960926124733
Annuals > 0 > ratios > ROE
-45.37263611747371
Annuals > 0 > ratios > ROA
-37.31449450355409
Annuals > 0 > ratios > FCF
-453653000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-6.1135098713024725
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
86180000
Annuals > 1 > income Statement > cost Of Revenue
572827000
Annuals > 1 > income Statement > gross Profit
-486647000
Annuals > 1 > income Statement > operating Expenses
197658000
Annuals > 1 > income Statement > operating Income
-684305000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-628194000
Annuals > 1 > income Statement > net Income
-615061000
Annuals > 1 > income Statement > eps
-4.5855271972926985
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
134130924
Annuals > 1 > income Statement > income Tax Expense
-13077000
Annuals > 1 > income Statement > EBITDA
-641637000
Annuals > 1 > income Statement > operating Margin
-794.0415409607797
Annuals > 1 > income Statement > total Other Income Expense Net
56111000
Annuals > 1 > balance Sheet > cash
241576000
Annuals > 1 > balance Sheet > short Term Investments
1280833000
Annuals > 1 > balance Sheet > receivables
11600000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
1588226000
Annuals > 1 > balance Sheet > property Plant Equipment
167200000
Annuals > 1 > balance Sheet > total Assets
1919060000
Annuals > 1 > balance Sheet > payables
6334000
Annuals > 1 > balance Sheet > short Term Debt
12867000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
328824000
Annuals > 1 > balance Sheet > equity
1590236000
Annuals > 1 > cash Flow > net Income
-615061000
Annuals > 1 > cash Flow > depreciation
19451000
Annuals > 1 > cash Flow > change In Working Capital
-304591000
Annuals > 1 > cash Flow > cash From Operations
-778785000
Annuals > 1 > cash Flow > capital Expenditures
21573000
Annuals > 1 > cash Flow > cash From Investing
164729000
Annuals > 1 > cash Flow > cash From Financing
7380000
Annuals > 1 > cash Flow > net Change In Cash
-606468000
Annuals > 1 > ratios > PE
-4.5855271972926985
Annuals > 1 > ratios > PB
0.571869624835559
Annuals > 1 > ratios > ROE
-38.677340973289496
Annuals > 1 > ratios > ROA
-32.05011828707805
Annuals > 1 > ratios > FCF
-800358000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-9.28705035971223
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1615797000
Annuals > 2 > income Statement > cost Of Revenue
620967000
Annuals > 2 > income Statement > gross Profit
994830000
Annuals > 2 > income Statement > operating Expenses
161762000
Annuals > 2 > income Statement > operating Income
833068000
Annuals > 2 > income Statement > interest Expense
183145000
Annuals > 2 > income Statement > pretax Income
754280000
Annuals > 2 > income Statement > net Income
515837000
Annuals > 2 > income Statement > eps
3.8263743465031776
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
134810908
Annuals > 2 > income Statement > income Tax Expense
238443000
Annuals > 2 > income Statement > EBITDA
839851000
Annuals > 2 > income Statement > operating Margin
51.55771424256884
Annuals > 2 > income Statement > total Other Income Expense Net
-78788000
Annuals > 2 > balance Sheet > cash
848631000
Annuals > 2 > balance Sheet > short Term Investments
1553409000
Annuals > 2 > balance Sheet > receivables
26400000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
2519077000
Annuals > 2 > balance Sheet > property Plant Equipment
188166000
Annuals > 2 > balance Sheet > total Assets
2802088000
Annuals > 2 > balance Sheet > payables
6422000
Annuals > 2 > balance Sheet > short Term Debt
4137000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
724125000
Annuals > 2 > balance Sheet > equity
2077963000
Annuals > 2 > cash Flow > net Income
515837000
Annuals > 2 > cash Flow > depreciation
6783000
Annuals > 2 > cash Flow > change In Working Capital
665367000
Annuals > 2 > cash Flow > cash From Operations
1663253000
Annuals > 2 > cash Flow > capital Expenditures
68006000
Annuals > 2 > cash Flow > cash From Investing
-1193461000
Annuals > 2 > cash Flow > cash From Financing
34761000
Annuals > 2 > cash Flow > net Change In Cash
504553000
Annuals > 2 > ratios > PE
3.8263743465031776
Annuals > 2 > ratios > PB
0.4398624788988062
Annuals > 2 > ratios > ROE
24.824166744066183
Annuals > 2 > ratios > ROA
18.409022129212214
Annuals > 2 > ratios > FCF
1595247000
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
0.987281818198697
Annuals > 2 > health Score
92
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1095415000
Annuals > 3 > income Statement > cost Of Revenue
513871000
Annuals > 3 > income Statement > gross Profit
581544000
Annuals > 3 > income Statement > operating Expenses
160793000
Annuals > 3 > income Statement > operating Income
420751000
Annuals > 3 > income Statement > interest Expense
272911000
Annuals > 3 > income Statement > pretax Income
549802000
Annuals > 3 > income Statement > net Income
528583999
Annuals > 3 > income Statement > eps
3.961296341169698
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
133437126
Annuals > 3 > income Statement > income Tax Expense
21218000
Annuals > 3 > income Statement > EBITDA
426562000
Annuals > 3 > income Statement > operating Margin
38.410191571230996
Annuals > 3 > income Statement > total Other Income Expense Net
129051000
Annuals > 3 > balance Sheet > cash
347815000
Annuals > 3 > balance Sheet > short Term Investments
360330000
Annuals > 3 > balance Sheet > receivables
773079000
Annuals > 3 > balance Sheet > inventories
8594000
Annuals > 3 > balance Sheet > total Current Assets
1562821000
Annuals > 3 > balance Sheet > property Plant Equipment
130054000
Annuals > 3 > balance Sheet > total Assets
1954268000
Annuals > 3 > balance Sheet > payables
6521000
Annuals > 3 > balance Sheet > short Term Debt
3927000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
522419000
Annuals > 3 > balance Sheet > equity
1431849000
Annuals > 3 > cash Flow > net Income
528584000
Annuals > 3 > cash Flow > depreciation
5811000
Annuals > 3 > cash Flow > change In Working Capital
-628394000
Annuals > 3 > cash Flow > cash From Operations
-47589000
Annuals > 3 > cash Flow > capital Expenditures
21817000
Annuals > 3 > cash Flow > cash From Investing
-140814000
Annuals > 3 > cash Flow > cash From Financing
100331000
Annuals > 3 > cash Flow > net Change In Cash
-88072000
Annuals > 3 > ratios > PE
3.961296341169698
Annuals > 3 > ratios > PB
0.6318429626867079
Annuals > 3 > ratios > ROE
36.91618313104245
Annuals > 3 > ratios > ROA
27.047672018372097
Annuals > 3 > ratios > FCF
-69406000
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
-0.06336046156023059
Annuals > 3 > health Score
73
Valuation > metrics > PE
-1.1742661545523303
Valuation > metrics > PB
1.1674980434192774
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-20.492577546985423
Profitability > metrics > ROA
-29.896606827394614
Profitability > metrics > Net Margin
-679.7541666666667
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.2805621920919284
Risk > metrics > Interest Coverage
-57.852901934623084
Risk > final Score
-171
Risk > verdict
High
Liquidity > metrics > Current Ratio
34.52166761561334
Liquidity > metrics > Quick Ratio
34.52166761561334
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-37
Prev Risks > 1
22
Prev Risks > 2
-45
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:23:15.564Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-10-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-1.17
Earnings History > 0 > eps Estimate
-0.8407
Earnings History > 0 > eps Difference
-0.3293
Earnings History > 0 > surprise Percent
-39.1697
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-07-30
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.8
Earnings History > 1 > eps Estimate
-0.7754
Earnings History > 1 > eps Difference
-0.0246
Earnings History > 1 > surprise Percent
-3.1726
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-30
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.88
Earnings History > 2 > eps Estimate
-0.8433
Earnings History > 2 > eps Difference
-0.0367
Earnings History > 2 > surprise Percent
-4.352
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-20
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.76
Earnings History > 3 > eps Estimate
-0.89
Earnings History > 3 > eps Difference
0.13
Earnings History > 3 > surprise Percent
14.6067
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-10-31
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-1.56
Earnings History > 4 > eps Estimate
-1.05
Earnings History > 4 > eps Difference
-0.51
Earnings History > 4 > surprise Percent
-48.5714
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-01
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-1.02
Earnings History > 5 > eps Estimate
-0.9
Earnings History > 5 > eps Difference
-0.12
Earnings History > 5 > surprise Percent
-13.3333
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-02
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.48
Earnings History > 6 > eps Estimate
-1.05
Earnings History > 6 > eps Difference
0.57
Earnings History > 6 > surprise Percent
54.2857
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-22
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.86
Earnings History > 7 > eps Estimate
-1.01
Earnings History > 7 > eps Difference
0.15
Earnings History > 7 > surprise Percent
14.8515
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-02
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-1.22
Earnings History > 8 > eps Estimate
-1.21
Earnings History > 8 > eps Difference
-0.01
Earnings History > 8 > surprise Percent
-0.8264
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-03
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-1.45
Earnings History > 9 > eps Estimate
-1.2
Earnings History > 9 > eps Difference
-0.25
Earnings History > 9 > surprise Percent
-20.8333
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-04
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-1.06
Earnings History > 10 > eps Estimate
-0.87
Earnings History > 10 > eps Difference
-0.19
Earnings History > 10 > surprise Percent
-21.8391
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-02-23
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.76
Earnings History > 11 > eps Estimate
-0.39
Earnings History > 11 > eps Difference
-0.37
Earnings History > 11 > surprise Percent
-94.8718
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-03
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
1.3
Earnings History > 12 > eps Estimate
-0.21
Earnings History > 12 > eps Difference
1.51
Earnings History > 12 > surprise Percent
719.0476
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-09
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.58
Earnings History > 13 > eps Estimate
0.1
Earnings History > 13 > eps Difference
-0.68
Earnings History > 13 > surprise Percent
-680
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-05
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
3.85
Earnings History > 14 > eps Estimate
3.78
Earnings History > 14 > eps Difference
0.07
Earnings History > 14 > surprise Percent
1.8519
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-02-24
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
3.92
Earnings History > 15 > eps Estimate
3.04
Earnings History > 15 > eps Difference
0.88
Earnings History > 15 > surprise Percent
28.9474
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-04
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
0.82
Earnings History > 16 > eps Estimate
0.02
Earnings History > 16 > eps Difference
0.8
Earnings History > 16 > surprise Percent
4000
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-05
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
0.46
Earnings History > 17 > eps Estimate
-0.48
Earnings History > 17 > eps Difference
0.94
Earnings History > 17 > surprise Percent
195.8333
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-06
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-1.32
Earnings History > 18 > eps Estimate
-0.21
Earnings History > 18 > eps Difference
-1.11
Earnings History > 18 > surprise Percent
-528.5714
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-02-25
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.83
Earnings History > 19 > eps Estimate
-0.7
Earnings History > 19 > eps Difference
-0.13
Earnings History > 19 > surprise Percent
-18.5714
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-10
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.67
Earnings History > 20 > eps Estimate
-0.6
Earnings History > 20 > eps Difference
-0.07
Earnings History > 20 > surprise Percent
-11.6667
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-11
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.27
Earnings History > 21 > eps Estimate
-0.62
Earnings History > 21 > eps Difference
0.35
Earnings History > 21 > surprise Percent
56.4516
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-12
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.71
Earnings History > 22 > eps Estimate
-0.53
Earnings History > 22 > eps Difference
-0.18
Earnings History > 22 > surprise Percent
-33.9623
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-26
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.69
Earnings History > 23 > eps Estimate
-0.67
Earnings History > 23 > eps Difference
-0.02
Earnings History > 23 > surprise Percent
-2.9851
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-19
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-4.6
Earnings History > 24 > eps Estimate
-3.71
Earnings History > 24 > eps Difference
-0.89
Earnings History > 24 > surprise Percent
-23.9892
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-28
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.705
Earnings History > 25 > eps Estimate
-0.71
Earnings History > 25 > eps Difference
0.005
Earnings History > 25 > surprise Percent
0.7042
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A12,916,663 Shares in Vir Biotechnology, Inc. $VIR Bought by ARCH Venture Management LLC - MarketBeat
12/13/2025
12,916,663 Shares in Vir Biotechnology, Inc. $VIR Bought by ARCH Venture Management LLC MarketBeat
Read more →Vir Biotechnology stock gets positive readthrough from Mirum’s Bluejay deal By Investing.com Investing.com Nigeria
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$17.2222
Analyst Picks
Strong Buy
2
Buy
5
Hold
2
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 84.89% of the total shares of Vir Biotechnology Inc
1.
SB INVESTMENT ADVISERS (UK) LTD(12.0101%)
since
2025/06/30
2.
BlackRock Inc(11.628%)
since
2025/06/30
3.
Vanguard Group Inc(9.5216%)
since
2025/06/30
4.
ARCH VENTURE CORP(9.2982%)
since
2025/06/30
5.
iShares Core S&P Small-Cap ETF(3.9731%)
since
2025/08/31
6.
State Street Corp(3.7826%)
since
2025/06/30
7.
FMR Inc(2.5617%)
since
2025/06/30
8.
Vanguard Total Stock Mkt Idx Inv(2.5251%)
since
2025/07/31
9.
Citadel Advisors Llc(2.4942%)
since
2025/06/30
10.
Dimensional Fund Advisors, Inc.(2.1653%)
since
2025/06/30
11.
Vanguard Small Cap Index(1.9327%)
since
2025/07/31
12.
Orbimed Advisors, LLC(1.7138%)
since
2025/06/30
13.
Geode Capital Management, LLC(1.6214%)
since
2025/06/30
14.
iShares Russell 2000 ETF(1.5588%)
since
2025/08/31
15.
Morgan Stanley - Brokerage Accounts(1.176%)
since
2025/06/30
16.
SPDR® S&P Biotech ETF(1.1579%)
since
2025/08/31
17.
Vanguard Small Cap Growth Index Inv(1.0823%)
since
2025/07/31
18.
FIAM Small Cap Core CIT Cl B(1.0821%)
since
2025/06/30
19.
Charles Schwab Investment Management Inc(0.9308%)
since
2025/06/30
20.
Goldman Sachs Group Inc(0.9287%)
since
2025/06/30
21.
Ikarian Capital, LLC(0.7689%)
since
2025/06/30
22.
Renaissance Technologies Corp(0.7663%)
since
2025/06/30
23.
Vanguard Institutional Extnd Mkt Idx Tr(0.7378%)
since
2025/07/31
24.
Aberdeen Group PLC(0.7248%)
since
2025/06/30
25.
Biotech Growth Ord(0.6793%)
since
2025/05/31
26.
Northern Trust Corp(0.6682%)
since
2025/06/30
27.
Fidelity Small Cap Index(0.6438%)
since
2025/06/30
28.
iShares S&P Small-Cap 600 Value ETF(0.6235%)
since
2025/08/31
29.
Schroder Investment Management Group(0.605%)
since
2025/06/30
30.
SPDR® Portfolio S&P 600™ Sm Cap ETF(0.6037%)
since
2025/08/29
31.
Artisan Partners Limited Partnership(0.5698%)
since
2025/06/30
32.
iShares Russell 2000 Value ETF(0.5696%)
since
2025/08/31
33.
VOLORIDGE INVESTMENT MANAGEMENT, LLC(0.5683%)
since
2025/06/30
34.
DFA US Targeted Value I(0.5585%)
since
2025/07/31
35.
Vanguard Strategic Equity Inv(0.5348%)
since
2025/06/30
36.
abrdn Healthcare Investors(0.5003%)
since
2025/08/31
37.
Vanguard Tax-Managed Small Cap Adm(0.4195%)
since
2025/07/31
38.
Dimensional US Targeted Value ETF(0.4096%)
since
2025/08/29
39.
Strategic Advisers Fidelity US TtlStk(0.3976%)
since
2025/07/31
40.
Artisan International Small-Mid Investor(0.3949%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-1.17
EPS Estimate
-0.8407
EPS Difference
-0.3293
Surprise Percent
-39.1697%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.